MICRONUCLEUS TEST OF MOFEZOLAC (N-22)

スポンサーリンク

概要

• 論文の詳細を見る

• A micronucleus test using BDF_1 male mice was conducted in order to evaluate the in vivo mutagenicity of mofezoldc (N-22). N-22 was orally administered at doses of 75, 150, 300 and 600 mg/kg, with a sampling time of 24hr. The frequency of polychromatic erythrocytes with micronuclei was 0.07-0.08% in the groups treated with N-22 and did not differ markedly from that of the vehicle control (0.13%). The present study indicates that N-22 has no in vivo mutagenic properties.

• 日本トキシコロジー学会の論文
• 1990-06-30

著者

• Ohuchida Akinobu

  Drug Safetey Lab. Taiho Pharmaceutical Co. Ltd.

• Furukawa Akemi

  Drug Safety Laboratory Taiho Pharmaceutical Co. Ltd.

関連論文

• 410 THE EFFECTS OF HAPTEN DENSITY ON THE ANTIGENICITY OF BPO-PROTEIN CONJUGATES IN GUINEA PIGS
• MUTAGENICITY TESTS OF MOFEZOLAC (N-22)
• Potassium oxonate modulation of 5-fluororacil-induced myelotoxicity in colony forming assay of hematopoietic precursor cells.
• IMMUNOTOXIC EFFECT OF LOW DOSE CISPLATIN IN MICE
• Immunotoxicity Study of Cisplatin
• MUTAGENICITY TESTS ON PROPIVERINE HYDROCHLORIDE
• MUTAGENICITY TEST OF CEFODIZIME SODIUM
• The different sensibility to 5-fluorouracil in three cell lines, mouse lymphoma L5178Ytk^ cells, human lymphoblastoid TK6 and WTK-1 cells. (MUTAGENICITY) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
• MICRONUCLEUS TEST OF MOFEZOLAC (N-22)

スポンサーリンク